Industry Education

Education at APHON's Annual Conference takes on many forms. Attendees can sign-up for non-CNE breakfast, lunch or dinner symposia presentations that take place in meeting space, as well as Corporate Showcase presentations in the theatre area of exhibit hall. And of course, be sure to meet with individually with the many commercial and non-profit organizations that exhibit at APHON — each exhibiting company brings new information and perspectives on how you can enhance patient care at your facility.
12:00 – 1:15 pm
Thursday, August 17

Patient Management in High-Risk Neuroblastoma — A Look at the Literature Non-CNE Lunch Symposium (SYMTHL)

Managing high-risk neuroblastoma patients receiving antibody therapy can be complex. Learn more about caring for these patients as we take an in-depth look at recently published literature. Hear directly from the authors as they discuss their institution-specific nursing practice guidelines.

Please note that while this optional event is included in the conference fee, selecting the event on the registration form is required to attend. Space is limited. 

united theraputics homepage

APHON thanks United Therapeutics for their generous support of this event.

12:30-1:45 pm
Saturday, August 19

ALL Treatment and Considerations around Asparginase Hypersensitivity Non-CNE Lunch Symposium (SYMS)

Discussion Topics:

 

  • Importance and Goals of Asparaginase Treatment in ALL
  • Clinical Impact of Asparaginase Hypersensitivity
  • Overview of hypersensitivity reactions (HSR) in the context of the immune cascade
  • Considerations when Differentiating Infusion Reactions from HSRs
  • Therapy Considerations after HSRs
  • Case Builder Activity

Please note that while this optional event is included in the conference fee, selecting the event on the registration form is required to attend. Space is limited. 

jazz homepage

APHON thanks Jazz Pharmaceuticals, Inc. for their generous support of this event.

6:15– 6:45 pm
Thursday, August 17

Splenomegaly: A Case Discussion

Enlargement of the spleen is associated with a wide variety of diseases ranging from infectious mononucleosis to myeloproliferative disorders. Visit this Corporate Showcase to learn about a chronic, progressive, and often misdiagnosed life-threatening disorder that may present with splenomegaly.

sanofi corporateshowcase

Presented by Sanofi Genzyme

Enlargement of the spleen is associated with a wide variety of diseases ranging from infectious mononucleosis to myeloproliferative disorders. Visit this Corporate Showcase to learn about a chronic, progressive, and often misdiagnosed life-threatening disorder that may present with splenomegaly.

1:40– 2:10 pm
Friday, August 18

The Thrombotic Microangiopathies in Your Clinical Practice: A Discussion on Identifying Patients With Atypical Hemolytic Uremic Syndrome

This presentation will:

  • Distinguish atypical hemolytic uremic syndrome (aHUS) from other thrombotic microangiopathies (TMAs) with similar clinical presentations.
  • Describe clinical considerations in the diagnosis of aHUS in patients with TMA.
  • Increase confidence in diagnosing aHUS in patients who present with complement-amplifying conditions.
  • Recognize the limitations of plasma therapy in aHUS.
  • Enhance understanding of factors that affect long-term management of patients with aHUS.

Alexion

Presented by Alexion Pharmaceuticals 

Speaker:

Lance D. Trainor, MD